Five-Alpha-Reductase Inhibitors for Prostate Cancer Prevention

    April 2008 in “ The Cochrane library ”
    Timothy J Wilt, Roderick MacDonald, Karen L. Hagerty … Barnett S. Kramer
    Studysummary This study concluded that five-alpha-reductase inhibitors may reduce prostate cancer risk but could increase the risk of high-grade prostate cancer in men regularly screened for the disease.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on cochranelibrary.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003
    2. The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia The New England Journal of Medicine · 1996
    3. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992

    Related research 1

    1. Regarding Prostate-Specific Antigen: Let's Not Shoot the Messenger QJM · 2011